Article Turró-Garriga O, Calvó-Perxas L, Vilalta-Franch J, Blanco-Silvente L, Castells X, Capellà D, Garre-Olmo J; Registry of Dementia of Girona Study Group (ReDeGi Study Group) "Measuring anticholinergic exposure in patients with dementia: A comparative study of nine anticholinergic risk scales." International Journal of Geriatric Psychiatry (2018): -. Blanco-Silvente L; Capellà D; Garre-Olmo J; Vilalta-Franch J, Castells X "Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer's disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients." BMC Geriatrics 18 (2018): 168-. Maria Giner-Soriano;Albert Roso-Llorach; Cristina Vedia Urgell; Xavier Castells; Dolors Capellà; Ignacio Ferreira-González; Josep Mª Elorza-Ricart; Marc Casajuana;Amelia Troncoso Mariño; Eduard Diògene; Bonaventura Bolíbar; C "Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database." Pharmacoepidemiology and Drug Safety 26 (2017): 97-107. Riera M, Castells X, Tobias A, Cunill R, Blanco L, Capellà D "Discontinuation of Pharmacological Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder: Meta-analysis of 63 Studies Enrolling 11,788 patients." Psychopharmacology 234 (2017): 2657-2671. Zamora A; Carrion C; Aymerich M; Castells X; Blanco L; Martin-Urda A; Paluzie G; Capellà D; Elousa R "Evaluation of a Clinical Decision Support System for Dyslipidemia Treatment (HTE-DLPR) by QoE Questionnaire." International Journal of Cardiovascular Practice 2 (2017): 10-16. Cunill R; Castells X; Tobias A; Capellà D "Efficacy, safety and variability in pharmacotherapy for adults with Attention Deficit Hyperactivity Disorder: a meta-analysis and meta-regression in over 9000 patients." Psychopharmacology 2 (2016): 187-197. Giner-Soriano, M; Roso-Llorach, A; Vedia Urgel,l C; Casellas, A; Ferreira-González, I; Capellà, D; Morros, R. "Drug therapy for rate and rhythm control in nonvalvular atrial fibrillation: a cross-sectional study with electronic health records in a primary care cohort." Clinical Therapeutics 38 (2016): 863-873. Giner-Soriano, M; Vedia Urgell, C; Roso-Llorach, A; Morros, R; Capellà, D; Castells, X; Ferreira-González, I; Troncoso Mariño, A; Diògene, D; Elorza, JM; Casajuana, M; Bolíbar, B; Violan, C. "Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database." BMJ Open 6 (2016): e010144-. Martinez-Zapata, M.J.; Vernooij, R.W.M.; Uriona Tuma, S.M.; Stein, A.T.; Moreno, R.M.; Vargas, E.; Capellà, D.; Bonfill Cosp, X. "Phlebotonics for venous insufficiency (Review) [Versió 3]." Cochrane Database of Systematic Reviews (2016): ArtNúm.CD003229-. Castells, X; Cunill, R; Pérez-Mañá, C; Vidal, X; Capellà, D. "Psychostimulant drugs for cocaine dependence." Cochrane Database of Systematic Reviews 9:CD007380 (2016): -. Bosch-Barrera J; Briceño HC; Capellà D; de Castro C; Farrés R; Quintanas A; Ramis J, Roca R; Brunet J "Enseñar bioética a estudiantes de medicina mediante el aprendizaje basado en problemas (ABP)." Cuadernos de Bioética XXVI (2015): 303-309. Cunill R; Castells X; Tobias A; Capellà D "Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence." Journal of Psychopharmacology 29 (2015): 15-23. Aymerich, M.; Rodriguez-Jareño, M.C.; Castells, X.; Carrion, C.; Zamora, A.; Capella, D. "Translational Research: A Concept Emerged from Health Sciences and Exportable to Education Sciences." Annals of Translational Medicine & Epidemiology 1 (2014): 1004-. Castells, X; Cunill, R; Capellà, D. "Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder:a meta-analysis of randomized clinical trials ." European Journal of Clinical Pharmacology 69 (2013): 347-356. Salgueiro, ME; Manso, G; Castells, X; Jimeno, FJ; Ordoñez, L; González, V; Rodríguez, A; Capellà, D. "Trends in the pharmacological treatment of osteoporosis in Spain from 2000 to 2008." Maturitas 74 (2013): 74-78. Cunill R; Castells X; Tobias A; Capellà D. "Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression. ." Pharmacoepidemiology and Drug Safety 22 (2013): 961-969. Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M. "Efficacy of Psychostimulant Drugs for Amphetamine Abuse or Dependence. Cochrane Database of Systematic Reviews ." Cochrane Database of Systematic Reviews (2013): -. García Gil MM; Ramon Blanes R; Ponjoan Thäns A; Fina Avilés F; Capellà Hereu D; Morros Pedrós R; Castells Cervelló X; Bolíbar Ribas B "La enfermedad de Alzheimer y otras demencias en el Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP)." Alzheimer. Realidades e investigación en demencia (2013): -. Pérez-Mañá C, Castells X, Casas M, Vidal X, C, Capellà D. "Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta-analysis of randomized controlled trials. ." Journal of Substance Abuse Treatment 40 (2011): 109-102. Fiz J; Durán M; Capellà D; Carbonell J; Farré M. "Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life." PLoS One 6 (2011): e18440-. Castells X, Casas M, Pérez-Mañá C, Roncero C, Vidal X, Capellà D. "Efficacy of Psychostimulant Drugs for Cocaine Dependence.." Cochrane Database of Systematic Reviews 2 (2010): -. Duran M, Pérez E, Abanades S, Vidal X, Saura C, Majem M, Arriola E, Rabanal M, Pasotr A, Farré M, Rams N, Laporte JR, Capellà D. "Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. ." British Journal of Clinical Pharmacology 70 (2010): 656-663. Castells X. Kosten TR, Capellà D, Vidal X, Colom J, Casas M. "Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: a systematic review and meta-analysis of controlled clinical trials." American Journal of Drug and Alcohol Abuse 35 (2009): 339-349. Castells X, Casas M, Vidal X, Bosch R, Roncero C, Ramos-Quiroga JA, Capellà D. "Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials.." Addiction 102 (2007): 1871-1887. Capella D, Vidal X "Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine." Age and Ageing 36 (2007): 234-234. Castells X, Vallano A, Rigau D, Pérez J, Casas M, Capellà D. "Trends in lithium prescription in Spain from 1985 to 2003. ." Journal of Affective Disorders 91 (2006): 273-276. Durán M, Abanades S, Farré M, Capellà D "Cannabinoides y emesis: nuevas evidencias, nuevas preguntas." Medicina Clinica 127 (2006): 237-238. Perez J, Marin N, Vallano A, Castells X, Capellà D. "Consumo y gasto de fármacos antipsicóticos ." Actas Españolas de Psiquiatría 33 (2005): 110-116. Vacca C, Orozco J, Figueras A, Capellà D. "Assessment of risks related to medicine dispensing by nonprofessionals in Colombia: clinical case simulations. ." Annals of Pharmacotherapy 39 (2005): 527-532. Durán M, de las Heras MJ, Laporte JR, Capellà D "Uso terapéutico del cannabis: resultados de una entrevista prospectiva en Cataluña." Medicina Clinica 124 (2005): 76-77. Montané E, Durán M, Capellà D, Figueras A "Scientific drug information in newspapers: sensationalism and low quality. The example of therapeutic use of cannabinoids. ." European Journal of Clinical Pharmacology 61 (2005): 475-477. Durán M, Capellà D "Cannabis y cannabinoides en el tratamiento del dolor neuropático ." dolor investigacion clinica y terapeutica 20 (2005): 213-216. Martinez-Zapata MJ, Bonfill Cosp X, Moreno RM, Vargas E, Capellà DMartinez-Zapata MJ, Bonfill Cosp X, Moreno RM, Vargas E, Capellà D "Phlebotonics for venous insufficiency (review) [versió 2]." Cochrane Database of Systematic Reviews (2005): Art.N.:CD003229-. Martinez-Zapata MJ, Bonfill Cosp X, Moreno RM, Vargas E, Capellà DMartinez-Zapata MJ, Bonfill Cosp X, Moreno RM, Vargas E, Capellà D "Phlebotonics for venous insufficiency (review) [versió 2]." Cochrane Database of Systematic Reviews (2005): Art.N.:CD003229-. Durán M, Laporte JR, Capellà D. "Novedades sobre las potencialidades terapéuticas del Cannabis y el sistema cannabinoide.." Medicina Clinica 122 (2004): 390-398. Durán M, Capellà D. "Uso terapéutico de los cannabinoides.." Adicciones 16 (2004): 143-152. Théophile H, Bégaud B, Martin K, Laporte JR, Capellà D. "Incidence of agranulocytosis in Southwest France.." European Journal of Epidemiology 19 (2004): 563-565. Llop R, Rodríguez D, Danés I, Capella D. "Avances y controversias en el tratamiento de la depresión." Atencion Primaria 31 (2003): 194-197. Castel JM, Figueras A, Pedrós C, Laporte JR, Capellà D. "Stimulating adverse drug reactions reporting – Effect of a Drug Safety Bulletin and of including yellow cards in the prescription pads." Drug Safety 26 (2003): 1049-1055. Capellà D, Pedrós C, Vidal X, Laporte JR "Case-population studies in pharmacoepidemiology ." Drug Safety 25 (2002): 7-19. Capellà D, Bosch M "Estatinas ¿beneficio o riesgo? ." Medicina Clinica 118 (2002): 335-336. Capellà D, Cereza G, Pedrós C "A propósito de los problemas relacionados con la medicación como causa del ingreso hospitalario." Medicina Clinica 119 (2002): 475-475. Capellà D. "Què aporten els nous antidepressius?." butlleti d'informacio terapeutica del consorci sanitari de barcelona 42 (2002): 1-2. Martinez, M.J.; Bonfill, X.; Moreno, R.M.; Cachà, A.; Vargas, E.; Capellà, D. "Phlebotonics for venous insufficiency [versió 1]." Cochrane Database of Systematic Reviews (2001): ArtNúmCD003229-. Ibáñez L, Ballarín E, Pérez E, Vidal X, Capellà D, Laporte JR "Agranulocytosis induced by pyrithyldione, a sedative hypnotic drug." European Journal of Clinical Pharmacology 55 (2000): 761-764. Capellà D, Bruguera M, Figueras A, Laporte JR "Fluoxetine-induced hepatitis: why is potsmarketing surveillance needed?." European Journal of Clinical Pharmacology 55 (1999): 545-546. Aguilera C, Capellà D "Uso de fármacos en geriatría." Medicine (Ed. español) 7 (1999): 5811-5815. Capellà D, Laporte JR, Vidal X, Wiholm BE, Bégaud B, Langman MJS, Rawlins M "European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study." European Journal of Clinical Pharmacology 53 (1998): 299-302. Belton KJ, Gram LF, Royer RJ, Feely J, McGettigan P, Velo GP, Conforti A, Leone R, Stricker BHCh, Teixeira F, Laporte JR, Capellà D, Beermann B, Lewis SC, Payne S, Rawlins MD, Wood SM "Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union." European Journal of Clinical Pharmacology 52 (1997): 423-427. Morros R, Figueras A, Capellà D, Laporte JR "Hypersensitivity vasculitis related to aceclofenac." British Journal of Rheumatology 36 (1996): 503-504. Laporte JR, Capellà D "Insuficiencia hepática fulminante por bendazaco ." Medicina Clinica 104 (1995): 396-396. Laporte JR, Capellà D "Signals generated by spontaneous reporting in Spain. Are they different or they just look different? ." Fundamental & Clinical Pharmacology 9 (1995): 292-292. Narváez M, Figueras A, Capellà D, Laporte JR "Tinnitus with calcium-channel blockers." The Lancet 343 (1994): 1229-1230. LLop R, Gómez-Farrán F, Figueras A, Capellà D, Laporte JR "Gynecomastia associated with enalapril and diazepam." Annals of Pharmacotherapy 28 (1994): 671-672. Alvarez P, Figueras A, Capellà D, Laporte JR "Calcitonin and epistaxis." Pharmacoepidemiology and Drug Safety 3 (1994): 41-42. Laporte JR, Capellà D "El Sistema Español de Farmacovigilancia." Medicina Clinica 103 (1994): 335-336. Figueras A, Capellà D, Laporte JR "Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations." European Journal of Clinical Pharmacology 47 (1994): 297-303. Capellà D "Las 'fórmulas' para adelgazar ¿solución milagrosa de un problema estético o fraude consumista?." clinica rural 428 (1994): 4-5. Figueras A, Castel JM, Laporte JR, Capellà D "Gemfibrozil-induced impotence." Dicp-the Annals of Pharmacotherapy 27 (1993): 982-982. Figueras A, Morales-Olivas FJ, Capellà D, Palop V, Laporte JR "Bovine gangliosides and acute motor polyneuropathy." British Medical Journal 305 (1992): 1330-1331. Capellà D, Torres F, Avila P, Moreno V, Laporte JR "Tos por inhibidores de la enzima conversiva de la angiotensina. Casuística reunida por notificación espontánea de reacciones adversas." Medicina Clinica 96 (1991): 126-128. Capellà D, Torres F, Laporte JR "Tos inducida por inhibidores de la enzima conversiva de la angiotensina." Medicina Clinica 97 (1991): 597-598. Azagra R, Aguyé L, Capellà D " Estudios cualitativos sobre prescripción en atención primaria ." Atencion Primaria 8 (1991): 434-435. Montaner F, Ortiz M, Capellà D, Ruíz J "Estomatitis aftosa por captopril." Atencion Primaria 7 (1990): 79-79. Laporte JR, Capellà D, Juan J "Agranulocytosis induced by cinepazide." European Journal of Clinical Pharmacology 38 (1990): 387-388. Laporte JR, Capellà D "Benzodiacepinas e insomnio: ¿deben ir siempre juntos? ." Medicina Clinica 95 (1990): 693-695. Capellà D " Farmacovigilancia en atención primaria ." revista de farmacologia clinica y experimental 7 (Suppl 2) (1990): 29-31. Martínez Martínez R, Gasulla G, Lafuente A, Capellà D "Nifedipina y recurrencia de epistaxis." Medicina Clinica 92 (1989): 476-476. Avila P, Capellà D, Laporte JR, Moreno V "Which salt of erythromycin is most hepatotoxic? ." The Lancet 1 (1988): 1104-1104. Capellà D, Avila P, Cabeza L, Moreno V, Vidal X, Laporte JR "Cuatro años de experiencia en farmacovigilancia ." Medicina Clinica 91 (1988): 93-96. Capellà D, Laporte JR, Castel JM, Tristán C, Cos A, Morales-Olivas FJ "Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine." British Medical Journal 297 (1988): 722-723. Laporte JR, Capellà D, Avila P "Enterocolitis neutropénica y pancitopenia atribuidas a las pirazolonas." Medicina Clinica 88 (1987): 607-607. Laporte JR, Capellà D "Useless drugs are not placebos ." The Lancet 1 (1987): 1324-1324. Laporte JR, Capellà D "El consumo de medicamentos ." Medicina Clinica 89 (1987): 244-246. Laporte JR, Capellà D. "El desarrollo de los métodos de farmacovigilancia." Medicine (Ed. español) 93 (1987): 545-552. Dolors Capellà; Joan-Ramon Laporte "La dependència de benzodiazepines." (Ciència) VI (1987): 53-56. Laporte JR, Capellà D "Useless drugs are not placebos: lessons from flunarizine and cinnarizine." The Lancet 2 (1986): 853-854. Capellà D, Cabeza D, Laporte JR "Sindrome maligno por neurolépticos y biperideno ." Medicina Clinica 85 (1985): 728-728. Laporte JR, Capellà D "El desarrollo de la farmacovigilancia en España." informacion terapeutica de la seguridad social 9 (1985): 129-135. Capellà D, Laporte JR "La notificació voluntària de reaccions adverses a medicaments. La targeta groga ." Annals de Medicina 70 (1984): 17-21. Laporte JR, Porta M, Capellà D, Arnau JM " Drugs in the Spanish health system." International Journal of Health Services 14 (1984): 635-648. Laporte JR, Capellà D "La notificación de posibles reacciones adversas a medicamentos en publicaciones médicas ." Medicina Clinica 83 (1984): 474-474. Laporte JR, Cabeza D, Capellà D "Detección de reacciones adversas a medicamentos: el programa de la tarjeta amarilla ." Jano. Medicina y Humanidades extra (1984): 70-75. Mas X, Laporte JR, Frati ME, Busquet L, Arnau JM, Ibáñez L, Séculi E, Capellà D, Arbonés G " Drug prescribing and use among elderly people in Spain ." Drug Intelligence and Clinical Pharmacy 17 (1983): 378-382. Laporte JR, Arnau JM, Capellà D, Porta M "Experiències d'informació sobre medicaments a Catalunya ." Gaceta Sanitaria 1 (1983): 26-33. Laporte JR, Capellà D, Porta M, Pardo L "Calidad del consumo de medicamentos en España en los últimos diez años ." Archivos de farmacologia y toxicologia. 9 (1983): 83-88. Laporte JR, Porta M, Capellà D "Drug utilization studies: a tool for determining the effectiveness of drug use ." British Journal of Clinical Pharmacology 16 (1983): 301-304. Capellà D, Porta M, Laporte JR " Utilization of antihypertensive drugs in certain European countries ." European Journal of Clinical Pharmacology 25 (1983): 431-435. Laporte JR, Porta M, Capellà D, Frati ME " La notificación voluntaria de reacciones adversas a medicamentos ." Medicina Clinica 79 (1982): 287-291. Porta, M.; Laporte, J.R.; Capellà, D.; Arnau, J.M. "Los medicamentos en la asistencia primaria." El Ciervo : revista mensual de pensamiento y cultura 375 (1982): 7-13. Article de divulgació Capellà D "La guia de la bona prescripció ." Annals de Medicina 82 (1998): 82-85. Article pendent de publicació Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, Capellà D "Discontinuation, efficacy and safety of cholinesterase inhibitors for Alzheimer's disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16,106 patients." International Journal of Neuropsychopharmacology 20 (2017): 519-528. Notes breus Cunill R; Castells X; Tobias A; Capellà D "Reply to the letter to the editor by Ramos-Quiroga et al." Pharmacoepidemiology and Drug Safety 23 (2014): 437-438.